In addition, for patients with severe bleeding, FXI concentrates and recombinant rFVIIa have also been used clinically to provide options for patients with coagulation factor XI deficiency [9]. This evidence concerns the gene F11 and hyperinsulinemic hypoglycemia, familial, 4.